1Foley RN.Parfrey PS.Complications of long-term dialysis:Cardi-ovascular complications and cardiac risk factor interventions,in Brow E and parfrey P:Complications of Long Term Dialysis[M].Oxford NY:Oxford University press,1999.29-52.
2Bhandari M,Brownjohn F,Tnruney F,et al.Effective utilization of erythropoietin with intravenous iron therapy[J].J Clin Pharm Ther,1998,23(1):73-78.
4Paganini EP.Hematologic Abnomatities[A].Daugirdas JT,Ing TS.Hand-book of Dialysis[M].Boston:Little Brown and Company,1994.445-468.
5Manaley HJ,Grabe DW.Determination of iron sucrose(Venofer)or iron dextran(DexFerrum)removal by hemodialysis:An in-vitro sudy[J].BMC Nephrol,2004.5(1):1-7.
6Riedel MK,Morgenstern T.Iron replacement in hemodialysis patients With a normal Serum ferritin leve[J].Dtsch Med Wochenschr,2004.129(36):1849-1853.
7St Peter WL,Obrador GT,Robert TL,et al.Trends in intravenous iron use among dialysis patients in the United States(1994-2002)[J].Am J Kidney Dis,2005,46(4):650-660.
8National Kidney Foundation.NKF-K/DOQI Clinical Practice Guidelines for Anemia of chronic kidney disease:update 2000[J].Am J Kidney Dis,2001,37(1 Suppl 1):S182-S238.
9Hood SA,OBrien M,Higgins R.The safety of intravenous iron dextran(Dexferrum) during hemodialysis in patients with end stage renal disease[J].Nephrol Nurs,2000,27(1):41-42.
10McCarthy JT,Regnier CE,Loebertmann CL,et al.Adverse eveuts in chronic hemodialysis patients receiving intravenous iron dextran-a comparison of two products[J].Am J Nephrol,2000.20(6):455-462.
4Silverberg DS, Blum M, Peer G, et al. Intravenous ferric saccha -rate as an iron supplement in dialysis patients[ J ]. Nephron, 1996, 72(3) : 413-417.
5刘玉村.牛津临床透析手册[M].北京:人民卫生出版社,2006:300-312.
6Riedel MK, Morgenstem T. Iron. replacement in hemodialysis patientswith a normal serum ferritin IeveI[ J ]. Dtsch Med Wochenschr, 2004, 129(36) : 1849-1853.
7St Peter WL, Obrador GT, Robert TL, et al. Trends in intTavenous iron use among dialysis patients in the United States( 1994 -2002) [ J]. Am J Kidney Dis, 2005, 46(4) : 650-660.
8Rogkakou, Guerra, Scordamaglia, et al. Severe skin reaction due to excipients of an oral iron treatment[ J]. Allergy, 2007, 62 ( 3 ) : 334- 335.
9Schaefer LS. ? Dialysis and Transplantation, 2000, 29(4) : 195-197.
10Georg SchalIer, Barbara Scheiber-mojdehkar, Michaelwolzt, et al. Intravenous iron increases labile serum iron but does not impair forearm blood flow reactivity in dialysis patients[ J]. Kidney International, 2005, 68:2814-2822.
